Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Chemotherapy for leukemia led to full hair regrowth in a child with alopecia totalis.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Lizard claws have hair-like keratins similar to those in mammals.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

TCF7L2 gene polymorphism is linked to alopecia areata, but it doesn't affect the success of PRP or conventional treatments.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Mice with autoimmune hair loss showed signs of heart problems.

Mice with alopecia areata had wider lymphatic vessels in their skin.

TCDD changes skin cell growth and keratin production in mice.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

CTCF protein is essential for skin and hair follicle development in mice.

Tabby mutations in mice affect hair follicle development and help study genetic mapping and certain medical conditions.

Inflammation damages sweat ducts, causing sweat gland injury.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Different γδ T cell types have unique roles in causing alopecia areata.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Cathepsin L is essential for heart health and its absence causes heart problems and hair loss.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

The Labrador dog fully recovered from hypothyroidism after 3 months of treatment.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.